top of page

12 juil. 2023
Theranexus raised €3.1 million to fund the Phase 3 development of Batten-1, with strong investor demand and BBDF becoming an 11.6% shareholder.
Lyon, Jul 13, 2023 – THERANEXUS raises around 3.1 million euros in fundraising
Download Theranexus press release
bottom of page
